🇺🇸 FDA
Patent

US 6497884

Chimeric vaccine against tick-borne encephalitis virus

expired A61KA61K2039/5254A61K38/00

Quick answer

US patent 6497884 (Chimeric vaccine against tick-borne encephalitis virus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5254, A61K38/00, A61K39/00